The frequent concurrence of both RHOA and IDH2 mutations in AITL argues for their oncogenic synergy, and together they most likely play an important role in malignant transformation and also underpin the morphological and immunophenotypic presentations as discussed earlier. Here, RHOA is linked to angioimmunoblastic T-cell lymphoma.